Advertisements

Лосек

Quick links to important sections

Лосек

Selected form

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Лосек

Quick Facts

Property Description
Active Ingredient Omeprazole (INN)
Forms Capsule, Tablet, Powder for Injection
Pharmacological Class Proton Pump Inhibitor (PPI)
General Purpose Reduction of gastric acid secretion
Origin Synthetic substituted benzimidazole

What is Лосек and Its Active Composition?

Лосек is a recognized brand name for the medication containing the active substance Omeprazole (INN). This drug is a synthetic substituted benzimidazole compound, distinguishing it chemically from older acid-reducing agents. As a single-component product, its formulation is highly focused: the oral versions are prepared as enteric-coated pellets contained within capsules or pressed into tablets. This specialized coating is crucial because the Omeprazole molecule is acid-labile, meaning it is protected from degradation in the stomach and ensures proper absorption in the small intestine. Omeprazole has been clinically recognized for decades as a first-line agent in the management of acid-related disorders.

The Pharmacological Class and General Purpose of Omeprazole

Omeprazole is the defining member of the Proton Pump Inhibitor (PPI) pharmacological class. This classification confirms its capacity for sustained acid control. Its general purpose is to deliver potent and reliable reduction of gastric acid secretion by achieving irreversible inhibition of the gastric H^+/K^+-ATPase enzyme (the proton pump). This mechanism is key to providing sustained relief from acid discomfort, such as that experienced in typical heartburn, and promoting the healing of damaged gastrointestinal tissues. The medication's availability as a lyophilized powder for injection solution for intravenous use provides an alternative route when oral delivery is temporarily not possible.

Regulatory References

  1. Omeprazole: MedlinePlus Drug Information
Advertisements

What side effects are possible with Лосек?

Possible side effects and safety information

The safety profile of Omeprazole (Лосек) is formally defined by regulatory documents, which classify potential adverse reactions based on frequency and affected system-organ class. The most Common adverse reactions typically involve the gastrointestinal and nervous systems, including headache, abdominal pain, diarrhea, and nausea/vomiting.

Reactions are also classified as Uncommon, Rare, or Very Rare, and these are grouped into various system categories. Rare but clinically significant reactions, termed Serious Adverse Reactions, are explicitly documented, such as Acute Tubulointerstitial Nephritis (AIN) and severe skin conditions like Stevens-Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN).


Exposure-Related Safety and Constraints

Official labels detail safety patterns associated with the duration of use. Long-term use (e.g., one year or longer) is formally associated with an increased risk of bone fracture (hip, wrist, or spine) and deficiencies in electrolytes and vitamins, specifically Hypomagnesaemia and Cyanocobalamin (Vitamin B-12) deficiency.

Safety constraints noted in regulatory texts include the warning that symptomatic response to the medicine does not rule out the presence of underlying gastric malignancy. The label also notes that caution is required in specific patient groups, such as those with pre-existing liver disease.


Frequency Classification Documented Examples (High-Level)
Common Headache, Abdominal pain, Diarrhea, Nausea/Vomiting
Uncommon Insomnia, Dizziness, Increased liver enzymes, Rash
Rare Hypersensitivity reactions, Tubulointerstitial nephritis, Arthralgia
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The information below is based strictly on documented findings and required actions outlined in official government regulatory documents.


Documented Overdose Manifestations

Official regulatory documents state that the clinical manifestations following an Omeprazole overdose are generally mild to moderate and transient.

Classification Symptoms and Signs
Gastrointestinal Nausea, vomiting, abdominal pain, diarrhea, flatulence.
CNS / Other Headache, drowsiness, confusion, dry mouth, blurred vision, and flushing.

Required Emergency Actions

Immediate medical attention is required for any suspected overdose. Regulatory guidance explicitly mandates specific actions based on the patient's condition:

  • Contact the Poison Control Helpline for specific management guidance.
  • Immediately call emergency services if the individual has collapsed, experienced a seizure, has trouble breathing, or is unable to be awakened.

No specific antidote is known for Omeprazole overdose. Therefore, treatment is directed toward symptomatic and general supportive measures. Due to its extensive protein binding, Omeprazole is documented as not readily dialyzable. Clinical observation is required until the patient achieves stabilization.

Advertisements

Therapeutic Uses of Лосек

What Лосек Treats: Main Uses and Benefits

This medication is applied in addressing conditions associated with symptoms related to heightened physiological activity. These conditions are often associated with symptoms that become more disruptive during flare-ups, such as heartburn and acid regurgitation.

This type of medicine is used to treat symptoms of Gastroesophageal Reflux Disease (GERD) and is relevant for managing conditions involving inflammatory or irritative states, such as peptic ulcers and erosive esophagitis. It is also considered relevant for the long-term management of chronic GERD and is commonly used to help with therapeutic contexts involving the H. pylori bacterium.

A key patient-oriented benefit is that it may provide support that helps ease the overall symptom burden during periods of heightened physiological activity and discomfort. It contributes to improved comfort during symptomatic episodes and is used for managing conditions where symptoms create noticeable physiological strain, such as when supportive symptom management is appropriate during the use of certain other medications.

“It supports patients during episodes of heightened discomfort and is relevant in clinical settings that involve acute or unstable symptom patterns.”


Quick Fact: Relief for Persistent Heartburn


Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Use of Omeprazole is strictly defined by regulatory guidelines, establishing clear limitations on who can and cannot use the medicine.

Contraindications (Must Not Use):

Use is absolutely contraindicated for individuals with known hypersensitivity to omeprazole, substituted benzimidazoles, or any formulation components. It must not be used concurrently with the antiviral medications nelfinavir or atazanavir, due to specific regulatory warnings. Use is also restricted by excipients in some oral formulations, excluding patients with specific hereditary sugar intolerances.

Age and Conditional Eligibility:

Adults are eligible for all approved uses. Pediatric use is restricted by age and weight; use is established for children over 1 year of age (10 kg) for certain acid-related conditions. Safety and effectiveness have not been established in children under 1 year of age.

Patients with impaired hepatic function must use the medicine with caution, as a reduced dose may be sufficient due to altered metabolism. A critical eligibility constraint is the mandatory exclusion of gastric malignancy prior to starting treatment, as Omeprazole can mask serious symptoms. Use is generally permitted during both pregnancy and lactation when clinically necessary, based on available regulatory data.

Advertisements

What should I know about interactions with other medicines?

Omeprazole, the active ingredient in Losec, can interact with numerous other medicines by affecting how the body processes them, either by altering stomach pH or by impacting liver enzymes, primarily CYP2C19.

Decreased Absorption of Medicines

Losec reduces stomach acid, which is necessary for the absorption of certain medications. This can lead to lower blood levels and reduced effectiveness of:

  • Antifungals: Such as ketoconazole, itraconazole, and posaconazole.
  • HIV/AIDS Medications: Including atazanavir and nelfinavir. Concomitant use with rilpivirine is generally not recommended.
  • Iron Supplements
  • Thyroid Hormones: Specifically levothyroxine.

Increased Blood Levels of Medicines

Omeprazole can slow the metabolism of other drugs, which may increase their concentration in the blood, potentially raising the risk of side effects. Examples include:

  • Diazepam (an anxiety/sedative medication)
  • Phenytoin (an anti-seizure medication)
  • Warfarin (a blood thinner, requiring careful monitoring of INR)
  • Digoxin (a heart medication)
  • Cilostazol (used for peripheral artery disease)

Reduced Effectiveness of Clopidogrel

Omeprazole inhibits the liver enzyme CYP2C19, which is required to convert the antiplatelet drug clopidogrel (Plavix) into its active form. This interaction can reduce the effectiveness of clopidogrel, increasing the risk of cardiovascular events. Alternative anti-ulcer treatments may be recommended.

Other Important Interactions

Interaction Type Affected Medicine Clinical Consideration
Reduced Omeprazole Effect St. John’s wort, rifampin These can speed up the breakdown of omeprazole, making it less effective.
Increased Methotrexate Levels Methotrexate Omeprazole may delay the elimination of methotrexate, potentially leading to toxicity.

Always inform your healthcare provider about all prescription and non-prescription drugs, vitamins, and herbal products you are taking.

Advertisements

Mechanism of Action

Targeted Enzyme Inhibition

Лосек ( omeprazole) is a prodrug that becomes selectively concentrated and activated within the highly acidic environment of the secretory canaliculi of the gastric parietal cells. This site-specific activation generates an active sulfenamide compound. This active metabolite then forms a covalent and irreversible bond with specific cysteine residues on the H^+/K^+-ATPase enzyme, commonly known as the proton pump, which is present on the apical membrane of the parietal cell.


Modulation of Gastric Acid Secretion Pathway

The irreversible binding physically incapacitates the proton pump, thereby inhibiting the final, essential step in the acid secretion cascade. This process blocks the movement of hydrogen ions (protons) into the stomach lumen, regardless of the stimulus (e.g., histamine, gastrin, or acetylcholine) driving the cell. The functional consequence is a sustained reduction in the rate and total amount of hydrochloric acid secreted by the stomach, leading to an altered pH equilibrium within the gastric lumen.

Advertisements

Dosage and Administration Information

The administration of Omeprazole is primarily oral, utilizing delayed-release capsules (10 mg, 20 mg, 40 mg) or a powder for oral suspension. The dosage form dictates the primary route, with intravenous use reserved for specialized clinical settings when oral intake is not feasible. The oral dose must be taken once daily before a meal, typically in the morning, which aligns with the drug’s intended action when the acid pumps are highly functional.

Standard Dosing Patterns

Most common conditions utilize a starting regimen of 20 mg or 40 mg once daily for defined short-term courses (e.g., 4 to 8 weeks). Conversely, regimens for H. pylori eradication require a dose of 20 mg twice daily as part of a combination therapy. For pathological hypersecretory conditions, the initial dose is 60 mg once daily, and total daily doses exceeding 80 mg must be divided and administered throughout the day.

Administration Specifics and Handling

The delayed-release formulation requires strict handling: the capsules must be swallowed whole, and the internal pellets must not be crushed or chewed to preserve the enteric coating. If a dose is missed, the instruction is to take it as soon as possible, or skip it if the next dose is due, with the explicit directive to not take two doses at once. Furthermore, dosage adjustments are required for specific populations, notably a reduction to 10 mg once daily for individuals with severe hepatic impairment.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Лосек (Omeprazole)

The clinical evaluation of Лосек (Omeprazole) was studied for its use in research, which involves a large volume of data, including numerous randomized controlled trials (RCTs) and systematic reviews. This overview describes the kinds of research that have been conducted and the areas where data are still emerging, using only information reported in scientific and regulatory sources.


Evidence for Symptom Relief and GERD

Research has been extensively used in research exploring how symptoms change over time for conditions characterized by fluctuating or episodic manifestations, particularly Gastroesophageal Reflux Disease (GERD). Studies primarily involve short-term randomized controlled trials (RCTs) where studies explored the drug's use alongside an inactive substance (placebo) or alongside other types of acid-reducing medicines. These trials examined patient-reported experiences by focusing on outcomes related to physical discomfort, such as the frequency and severity of heartburn and regurgitation. The findings describe patterns observed in the studies regarding the proportion of subjects who reported changes in symptoms over a typical acute treatment period of a few weeks.

What remains uncertain in this area is primarily related to the long-term effects are not fully established regarding sustained symptom control. While many studies research explored short-term changes, information detailing how symptoms behave over periods of several years relies more heavily on less structured, observational settings evaluating daily-life functioning, where evidence quality varies across studies.


Evidence for Healing of Esophageal and Peptic Ulcer Damage

Clinical research has focused on research exploring healing outcomes for tissue damage for conditions involving outcomes linked to inflammatory or irritative states, such as erosive esophagitis and active peptic ulcers. Multi-center clinical trials measured the endoscopic healing rate. For peptic ulcers, similar RCTs research examined the rate and time required for changes in ulcer closure. Research provides insight into how patients reported their experience of associated symptoms during the observation period.


Research on Combination Therapy for H. pylori

The drug was evaluated in a significant number of Randomized Controlled Trials (RCTs) and systematic reviews exploring its function as one component within a multi-drug regimen—typically including antibiotics—aimed at research questions about the Helicobacter pylori bacterium. This bacterium was associated with many cases of peptic ulcer disease. These studies monitored the eradication rate as the main outcome and often research described outcomes related to the recurrence of ulcers. This research is limited to the drug's role in the combination regimen; data for the drug's use alone for H. pylori eradication are limited in current regulatory summaries.

Key Studies & References

  1. Omeprazole: a review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs - NCBI
  2. A systematic review of proton pump inhibitors for the treatment of adult patients with symptomatic gastroesophageal reflux disease or peptic - Gov.bc.ca (Systematic Review Summary)
  3. Omeprazole vs Lansoprazole in the Management of Gastroesophageal Reflux Disease: A Systematic Literature Review | Journal of Medical Research and Innovation
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Лосек (FAQ)

Q: How quickly does Лосек start to work?

According to official product information, this medicine is not intended for immediate relief of symptoms. While some patients may notice relief within the first 24 hours, the full therapeutic effect of the drug, which is intended to provide sustained acid suppression, may take 1 to 4 days to become noticeable.

Q: Is it normal to feel a difference after the first few days of using Лосек?

Official labeling indicates that feeling a difference after the first few days of use is a possible pattern for many patients. Since the full therapeutic benefit may take up to 4 days to be achieved, experiencing symptom relief within this timeframe is consistent with the timeframe for the medicine's full effect as noted in official sources.

Q: What is the longest time a person can use Лосек?

Regulatory documents describe that for standard conditions like frequent heartburn, treatment is typically a short, defined course. However, for certain complex conditions such as pathological hypersecretory conditions, the medication is approved for use for as long as clinically necessary. Regulatory data includes records of some patients having received treatment for longer than 5 years.

Q: Can Лосек affect my mood or sleep?

Official safety summaries indicate that adverse effects affecting the central nervous system are possible. These commonly include feeling dizzy or experiencing insomnia, which is a type of sleep disturbance. Changes in experience or persistent concerns should be discussed with the prescribing healthcare provider.

Q: Can Лосек be used for a persistent cough?

The medicine is primarily indicated for acid-related disorders like GERD and ulcers, and a persistent cough is not an approved treatment indication. Some regulatory-related studies have, however, noted that cough itself has been reported as an adverse effect in a small percentage of patients in clinical trials.

Q: Can Лосек interact with supplements or vitamins?

Yes, official drug information indicates that the medicine can interact with certain nutrients and supplements. Long-term use of the drug is formally associated with potential deficiencies of Vitamin B-12 and the electrolyte magnesium (Hypomagnesaemia). It can also alter the way the body absorbs supplements like iron salts.

Q: Does alcohol change how Лосек works in the body?

Official regulatory reviews focused on drug interactions have generally not found a direct interaction between the medicine and alcohol. Regulatory documents indicate that while no direct drug interaction is generally found, it is always recommended to discuss alcohol consumption with a healthcare provider.

Q: Can people with kidney problems use Лосек?

Dose adjustment is generally not needed for patients with impaired renal function. The medicine’s label does note that a serious adverse reaction called Acute Tubulointerstitial Nephritis (AIN), a type of kidney inflammation, has been documented in rare cases.

Q: What are the signs that Лосек is not working for me?

Regulatory information suggests that if symptom control for conditions like GERD has not been achieved after four weeks of treatment, this is typically the point where a re-evaluation of the treatment plan is warranted. This information does not replace professional guidance.

Q: What is the difference between prescription and over-the-counter (OTC) Лосек?

The key differences are the approved conditions and duration of use. The OTC version is typically available for the short-term treatment of frequent heartburn in adults for a 14-day course. Prescription-strength forms, however, treat a wider range of severe acid-related conditions and can be used for longer, medically supervised periods.

Q: Do researchers know why some people have to take Лосек for a long time?

Studies and regulatory summaries indicate that long-term therapy may be necessary for specific, persistent conditions. This includes chronic states like severe erosive esophagitis or conditions where the body overproduces acid, known as pathological hypersecretory conditions.

Q: Is it normal to have some digestive changes, like diarrhea or constipation, while on Лосек?

Official summaries of adverse effects indicate that digestive changes are possible. Diarrhea and abdominal pain are listed among the most frequent effects. Constipation is also reported as an adverse effect in a small percentage of patients during clinical trials.

Q: Are there any reported interactions between Лосек and diabetes medication?

Official regulatory texts note potential interactions with certain medications used for diabetes. For example, the use of this medicine may increase the levels of drugs like gliclazide, which may be associated with an increased risk of hypoglycemia (low blood sugar).

Q: Can I take Лосек if I have a history of heart issues?

While the medicine itself is not directly contraindicated for general heart issues, official warnings advise caution regarding its use with certain antiplatelet medications, such as clopidogrel. The concern is that the medicine may reduce the antiplatelet drug’s effectiveness, and an alternative acid treatment may be referenced in regulatory information as an option for this context.

Q: What are the general expectations for relief when using Лосек for GERD?

Official labeling states that the medicine provides sustained acid reduction, and it may take 1 to 4 days for the full effect to be felt. It is designed to relieve symptoms such as heartburn over a course of treatment, with some people reporting relief within the first 24 hours.

Q: Can I split a Лосек capsule or tablet?

The enteric-coated pellets contained within the capsules or tablets must not be crushed or chewed to ensure the medicine is properly protected from stomach acid. Official documentation notes that cutting or dividing certain formulations, such as a tablet, should only be done if the formulation is specifically designed for such use.

Q: Is there evidence that Лосек helps with laryngopharyngeal reflux (LPR)?

While the drug is not officially indicated for LPR (a condition where acid backs up into the throat and voice box), regulatory-related literature indicates that the use of this class of medicine is sometimes used as an empirical therapeutic trial to see if it helps reduce LPR-related symptoms.

Q: How is the use of Лосек described in older adults?

Official product information states that no dose adjustment is generally required for older adults (those over 65 years old). However, it is noted that for long-term use, official criteria or regulatory summaries suggest evaluating use beyond eight weeks unless the need is strongly documented.

Q: Does the drug’s reduction of acid affect my immune system or ability to fight infection?

Official regulatory-related texts note that the potent acid-suppressing nature of this class of medicine can increase the risk of certain gut infections. For instance, an increased risk of a severe intestinal infection called Clostridium difficile-associated diarrhea (CDAD) is noted in association with the use of this medication.

Advertisements

How should Лосек be stored and disposed of?

Storage Conditions

Losec (Omeprazole) must be stored under specific environmental and temperature controls to maintain its labeled stability. The product generally must not be stored above 30 C and should be kept in a cool, dry place protected from moisture and light.

Storage Classification Requirement
Temperature Limit Do not store above 30 C
Environmental Protection Protect from moisture and light
Container Rule Keep bottle tightly closed or store in the original package (blister)
In-Use Stability Use within 100 days after first opening the HDPE bottle (where applicable)

Disposal and Safety

All medicines, including Losec, must be kept out of the sight and reach of children. For disposal, any unused or expired product must be handled in accordance with local requirements. Official regulatory information often states no special disposal requirements beyond adherence to standard local procedures for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Лосек found in:

A-Z Index: